Depression

Investigators determined the effectiveness of behavioral activation psychotherapy versus antidepressant medication management for inpatients with heart failure and depression.

As the body of data has grown, clinicians’ propensity to use selective serotonin reuptake inhibitors off-label has increased

Gepirone does not induce sexual dysfunction, a common limitation associated with SSRIs.

The investigators note that psilocybin’s effectiveness in treating depressive symptoms and the positive reception among patients with cancer are encouraging continued research.

These drugs have interesting mechanisms, unique use, or may support expanded indications in the future.

By combining the administration of psychedelic compounds with therapeutic support, ketamine-assisted therapy is proving remarkable efficacy in treating mental health conditions.

Pharmacists are accessible and trusted health care professionals who have an important role in supporting people living with mental illness.

Modern society has put individuals at an increased risk of dopamine overload, causing an increase in mental health disorders.

Person-centered care focuses on tailoring treatment plans, providing medication support, and ensuring access to resources that meet their unique needs.

Taking pharmacists out of the dispensing setting and placing them in communities as educators on drug safety is reaping rewards.

Latinx teens suffering with mental health issues are at risk of developing cardiovascular conditions in their future.

A specialist in adult, child, and adolescent psychiatry discusses the challenges in ADHD treatment for both patients and providers, as well as insights from a recent survey of health care professionals.

In the clinical setting, psychedelic medicine has promise as a safe and efficacious treatment for PTSD, TBIs, and other mental health issues.

Mental health treatment may be necessary when SAEs occur.

Adolescents with mental health conditions must be monitored as they are at a higher demand for the need of mental health care.

Patients under the care of psychiatric facilities, particularly those taking antipsychotic and antidepressant medications, face the risk of prolonged QTc intervals.

Individuals treated with esketamine were more likely to reach remission and remain relapse-free at 8 weeks of treatment.

Use of antidepressants and other classes of prescription drugs can increase the risk of driving impairment compared to nonuse, so clinicians and pharmacists should review these risks with older adults.

The use of psilocybin, repeated at a low dose, could offer a new form of treatment for individuals with differing forms of mental disorders.

Ketamine topical cream may alleviate symptoms of PTSD without causing the adverse effects and abuse potential often associated with other forms of ketamine administration.

An overview of antidepressant medications and their indications to inform health care professionals of their wide use and to better understand which antidepressant to recommend based on patient-specific characteristics.

Gepirone hydrochloride ER (Exxua; Fabre-Kramer Pharmaceuticals Inc) is in a new class of antidepressants, making it the first and only approved antidepressant that selectively targets serotonin 1A receptors.

Study findings showed a 10% increase in the proportion of individuals staying home due to COVID-19 policy restrictions being associated with a 0.27 increase in PHQ-9 scores for depression.

To promote positive mental health outcomes, researchers urge for policy interventions that focus on home connectedness, peer friendship, and school climate while avoiding full school closures.